ProfileGDS4718 / 234979_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 57% 61% 60% 62% 72% 66% 65% 65% 62% 65% 59% 64% 70% 70% 54% 69% 69% 74% 52% 63% 63% 69% 58% 64% 71% 60% 69% 60% 61% 61% 68% 58% 65% 64% 68% 66% 61% 63% 63% 68% 60% 68% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0074358
GSM549102patient 115, normal, homogenized [OPG study]5.9591457
GSM549104patient 119, normal, homogenized [OPG study]6.1884161
GSM549108patient 138, normal, homogenized [OPG study]6.1289960
GSM549119patient 077, normal, homogenized [OPG study]6.2457662
GSM549133patient 032, cancer, homogenized [OPG study]7.0800872
GSM549139patient 042, cancer, homogenized [OPG study]6.5393166
GSM549099patient 107, normal, homogenized [OPG study]6.455665
GSM549109patient 139, normal, homogenized [OPG study]6.4509765
GSM549110patient 046, normal, homogenized [OPG study]6.2230962
GSM549114patient 063, normal, homogenized [OPG study]6.4568365
GSM549122patient 082, normal, homogenized [OPG study]6.0590259
GSM549134patient 033, cancer, homogenized [OPG study]6.4004864
GSM549136patient 036, cancer, homogenized [OPG study]6.8992570
GSM549140patient 044, cancer, homogenized [OPG study]6.8904470
GSM549111patient 047, normal, homogenized [OPG study]5.7179454
GSM549113patient 057, normal, homogenized [OPG study]6.7947769
GSM549132patient 031, cancer, homogenized [OPG study]6.8220569
GSM549137patient 038, cancer, homogenized [OPG study]7.2760774
GSM549142patient 047, cancer, homogenized [OPG study]5.7785152
GSM549100patient 110, normal, homogenized [OPG study]6.2949363
GSM549107patient 135, normal, homogenized [OPG study]6.3164563
GSM549115patient 068, normal, homogenized [OPG study]6.8354669
GSM549116patient 072, normal, homogenized [OPG study]5.9948258
GSM549120patient 078, normal, homogenized [OPG study]6.4142864
GSM549131patient 030, cancer, homogenized [OPG study]7.0119971
GSM549118patient 074, normal, homogenized [OPG study]6.1265860
GSM549129patient 027, cancer, homogenized [OPG study]6.8758969
GSM549123patient 088, normal, homogenized [OPG study]6.1431960
GSM549124patient 006, cancer, homogenized [OPG study]6.168561
GSM549126patient 015, cancer, homogenized [OPG study]6.1508361
GSM549128patient 025, cancer, homogenized [OPG study]6.7853968
GSM549103patient 117, normal, homogenized [OPG study]6.0224358
GSM549117patient 073, normal, homogenized [OPG study]6.4082565
GSM549138patient 041, cancer, homogenized [OPG study]6.4568964
GSM549141patient 045, cancer, homogenized [OPG study]6.805568
GSM549130patient 028, cancer, homogenized [OPG study]6.5437766
GSM549101patient 111, normal, homogenized [OPG study]6.239161
GSM549105patient 128, normal, homogenized [OPG study]6.3697363
GSM549106patient 134, normal, homogenized [OPG study]6.3767263
GSM549112patient 048, normal, homogenized [OPG study]6.6844468
GSM549125patient 011, cancer, homogenized [OPG study]6.1323160
GSM549127patient 024, cancer, homogenized [OPG study]6.7755768
GSM549135patient 035, cancer, homogenized [OPG study]7.0900872